デフォルト表紙
市場調査レポート
商品コード
1633543

心臓補助装置の市場規模、シェア、成長分析:製品タイプ別、設置場所別、モダリティタイプ別、地域別 - 産業予測、2025年~2032年

Cardiac Assist Devices Market Size, Share, Growth Analysis, By Product Type (Total Artificial Heart, Intra-Aortic Balloon Pumps ), By Placement Location, By Modality Type, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 241 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
心臓補助装置の市場規模、シェア、成長分析:製品タイプ別、設置場所別、モダリティタイプ別、地域別 - 産業予測、2025年~2032年
出版日: 2025年01月14日
発行: SkyQuest
ページ情報: 英文 241 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓補助装置の世界市場規模は、2023年に37億4,000万米ドルと評価され、2024年の42億5,000万米ドルから2032年には118億8,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは13.7%で成長する見通しです。

世界の心臓補助装置市場は、心不全や関連する心疾患を患う患者に一時的または長期的なサポートを提供することに重点を置いた医療機器産業の重要なセグメントです。心血管疾患の有病率が上昇し、高齢化も進んでいることから、これらの医療機器に対する需要は急増しています。小型化、バッテリー寿命の向上、低侵襲植え込み技術などの主要な進歩は、機器の効率と利用しやすさを向上させることで市場の成長を促進しています。特に、心臓移植を待つ患者や手術不適格者の代替手段として利用されるこの市場は、革新的な研究開発に投資する既存企業と新規参入企業の間で激しい競争が繰り広げられています。この分野は、技術の進歩と患者の予後向上へのコミットメントによって大きな可能性を秘めています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術の進歩

心臓補助装置市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • 完全人工心臓(TAH)
  • 大動脈内バルーンポンプ(IABP)
  • 心室補助装置(VAD)

心臓補助装置市場規模:設置場所別& CAGR(2025-2032)

  • 市場概要
  • 右心室補助装置(RVAD)
  • 左心室補助装置(LVAD)
  • 体外式心室補助装置(VAD)
  • 両心室補助装置(Bi-VAD)

心臓補助装置市場規模:モダリティタイプ別& CAGR(2025-2032)

  • 市場概要
  • 経皮型
  • 埋め込み型

心臓補助装置市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

心臓補助装置市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Berlin Heart GmbH(Germany)
  • Biotronik SE & Co. KG(Germany)
  • ReliantHeart Inc.(United States)
  • SynCardia Systems, LLC(United States)
  • Teleflex Incorporated(United States)
  • Levitronix GmbH(Switzerland)
  • Jarvik Heart, Inc.(United States)
  • Sunshine Heart, Inc.(United States)
  • CardiacAssist, Inc.(TandemLife)(United States)
  • CorWave SA(France)
  • Evaheart, Inc.(Japan)
  • FineHeart SA(France)
  • Windmill Cardiovascular Systems, Inc.(United States)
  • CARMAT(France)
  • Calon Cardio-Technology Ltd.(United Kingdom)
  • NewHeart Medical Devices, LLC(United States)
  • MiTiHeart Corporation(United States)
  • CircuLite, Inc.(United States)
  • CardioBridge GmbH(Germany)

結論と推奨事項

目次
Product Code: SQMIG35A2363

Global Cardiac Assist Devices Market size was valued at USD 3.74 billion in 2023 and is poised to grow from USD 4.25 billion in 2024 to USD 11.88 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).

The global Cardiac Assist Devices market represents a vital segment of the medical device industry, focused on providing temporary or long-term support for patients suffering from heart failure and related cardiac conditions. With the rising prevalence of cardiovascular diseases and a significant aging population, the demand for these devices is surging. Key advancements, including miniaturization, enhanced battery life, and minimally invasive implantation techniques, are fueling market growth by improving device efficiency and accessibility. Notably utilized for patients awaiting heart transplants or as alternatives for those ineligible for surgery, the market features intense competition among established firms and newcomers alike, all investing in innovative R&D. This sector holds substantial potential, driven by technological advancements and a commitment to enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Assist Devices Market Segmental Analysis

Global Cardiac Assist Devices Market is segmented by Product Type, Placement Location, Modality Type, End User and region. Based on Product Type, the market is segmented into Total Artificial Heart (TAH), Intra-Aortic Balloon Pumps (IABP) and Ventricular Assist Devices (VAD). Based on Placement Location, the market is segmented into Right Ventricular Assist Device (RVAD), Left Ventricular Assist Device (LVAD), External Ventricular Assist Device (VAD) and Bi-Ventricular Assist Device (Bi-VAD). Based on Modality Type, the market is segmented into Transcutaneous and Implantable. Based on End User, the market is segmented into Hospital, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Assist Devices Market

A significant driving force behind the global Cardiac Assist Devices market is the escalating prevalence of cardiovascular diseases, particularly coronary artery disease. Factors such as unhealthy dietary habits, sedentary lifestyles, and overall lifestyle modifications are exacerbating the incidence of these conditions worldwide. As cardiovascular diseases become increasingly common, the demand for innovative cardiac assist technologies rises correspondingly, prompting healthcare providers to seek advanced solutions to address this public health crisis. This growing need not only highlights the urgency for effective treatment options but also propels the development and adoption of cardiac assist devices, ultimately shaping the market landscape.

Restraints in the Global Cardiac Assist Devices Market

The global cardiac assist devices market faces several restraints, primarily stemming from technical challenges. Despite the ongoing technological advancements in this field, the effective implantation, management, and monitoring of these devices demand a skilled workforce and specialized infrastructure. The intricacies and steep learning curves involved can hinder healthcare providers' ability to adopt these devices widely. Consequently, this limitation poses a significant barrier to the market's growth, as adequate training and resources are essential to ensure optimal functioning and patient safety. As a result, these technical difficulties may restrict the widespread use of cardiac assist devices within the healthcare system.

Market Trends of the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market is witnessing a notable trend towards patient-centric design, reflecting a heightened emphasis on enhancing user experience and overall wellbeing. Manufacturers are increasingly prioritizing innovations that improve comfort and portability by minimizing device size and operational noise, while also addressing complications linked to implantation. This shift not only aims to enhance the quality of life for patients but also encourages patient compliance and satisfaction. As a result, companies are investing in advanced technologies and ergonomic designs, which is anticipated to drive market growth and shape competitive strategies in the evolving landscape of cardiac assist devices.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Cardiac Assist Devices Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Total Artificial Heart (TAH)
  • Intra-Aortic Balloon Pumps (IABP)
  • Ventricular Assist Devices (VAD)

Global Cardiac Assist Devices Market Size by Placement Location & CAGR (2025-2032)

  • Market Overview
  • Right Ventricular Assist Device (RVAD)
  • Left Ventricular Assist Device (LVAD)
  • External Ventricular Assist Device (VAD)
  • Bi-Ventricular Assist Device (Bi-VAD)

Global Cardiac Assist Devices Market Size by Modality Type & CAGR (2025-2032)

  • Market Overview
  • Transcutaneous
  • Implantable

Global Cardiac Assist Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospital
  • Ambulatory Surgical Centers
  • Others

Global Cardiac Assist Devices Market Size & CAGR (2025-2032)

  • North America (Product Type, Placement Location, Modality Type, End User)
    • US
    • Canada
  • Europe (Product Type, Placement Location, Modality Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Placement Location, Modality Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Placement Location, Modality Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Placement Location, Modality Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Berlin Heart GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ReliantHeart Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SynCardia Systems, LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Levitronix GmbH (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jarvik Heart, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sunshine Heart, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardiacAssist, Inc. (TandemLife) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CorWave SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evaheart, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FineHeart SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Windmill Cardiovascular Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARMAT (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Calon Cardio-Technology Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NewHeart Medical Devices, LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MiTiHeart Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CircuLite, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioBridge GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations